117th Congress · HOUSE BILLBILL

H.R. 7035 — Biologics Market Transparency Act of 2022

“To amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.”

Health

Introduced Mar 9, 2022

Last action Mar 10, 2022

Pipeline · Bill → Law

Step 1

Introduced

Mar 9, 2022

Step 2

Referred

Mar 10, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Mar 10, 2022

Referred to the Subcommittee on Health.

Mar 9, 2022

Introduced in House

Mar 9, 2022

Referred to the House Committee on Energy and Commerce.